These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma. Grootkerk-Tax MG, Soussan AA, de Haas M, Maaskant-van Wijk PA, van der Schoot CE. Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327 [Abstract] [Full Text] [Related]
7. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies. Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, Vlk R. J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007 [Abstract] [Full Text] [Related]
8. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Müller SP, Bartels I, Stein W, Emons G, Gutensohn K, Köhler M, Legler TJ. Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461 [Abstract] [Full Text] [Related]
15. [Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother--secondary publication]. Clausen FB, Krog GR, Rieneck K, Nielsen LK, Lundquist R, Finning K, Dickmeiss E, Hedegaard M, Dziegiel MH. Ugeskr Laeger; 2006 Jun 26; 168(26-32):2568-70. PubMed ID: 16824414 [Abstract] [Full Text] [Related]